Immunoglobulin replacement therapy in children.
(9/205)
(+info )How much does pharmacologic prophylaxis reduce postoperative vomiting in children? Calculation of prophylaxis effectiveness and expected incidence of vomiting under treatment using Bayesian meta-analysis.
(10/205)
(+info )Fixed dosing and pharmacokinetics of S-1 in Japanese cancer patients with large body surface areas.
(11/205)
(+info )Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy.
(12/205)
(+info )Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression.
(13/205)
(+info )Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations.
(14/205)
(+info )Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma.
(15/205)
(+info )Adaptive therapy.
(16/205)
(+info )